Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001174475-26-000004

Director sold 1,929 shares at $875.00 ($1,687,875)

  • Director acquired 1,929 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BROWN MICHAEL S · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-30 Exercise or conversion : show line 1 in the form 10b5-1 +1,929 $725.89 $1,400,242 3,309 D
2026-10-30 Sale : show line 2 in the form 10b5-1 −1,929 $875.00 $1,687,875 1,380 D
Open-market sales · 1,929 sh · avg $875.00 · $1,687,875

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-30 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −1,929 0 D
Loading xslF345X06/edgardoc.xml…